Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction.
Aged
Anastomosis, Surgical
/ methods
Anastomotic Leak
/ etiology
Bevacizumab
/ administration & dosage
Cohort Studies
Colorectal Neoplasms
/ drug therapy
Cytoreduction Surgical Procedures
/ methods
Female
Humans
Ileostomy
/ methods
Neoadjuvant Therapy
Neoplasm Staging
Ovarian Neoplasms
/ drug therapy
Practice Patterns, Physicians'
Retrospective Studies
Anastomotic leak
Diverting ileostomy
Ovarian cancer
Risk factors
Journal
Gynecologic oncology
ISSN: 1095-6859
Titre abrégé: Gynecol Oncol
Pays: United States
ID NLM: 0365304
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
11
04
2020
accepted:
27
05
2020
pubmed:
24
6
2020
medline:
16
4
2021
entrez:
24
6
2020
Statut:
ppublish
Résumé
To determine the factors related with diverting ileostomy performance after colorectal resection and anastomosis, in advanced ovarian cancer cytoreductive surgery. We have previously demonstrated the risk factors associated with anastomotic leak after colorectal anastomosis: Advanced age at surgery, low serum albumin level, additional bowel resections, manual anastomosis and distance of the anastomosis from the anal verge. However, use of diverting ileostomy is strongly variable and depends on individual surgeon preferences and training. Eight hospitals participated in this retrospective study. Data of 695 patients operated for ovarian cancer with primary colorectal anastomosis were included (January 2010-June 2018). Fourteen pre-/intraoperatively defined variables were identified and analysed as justification factors for use of diverting ileostomy. The rate of diverting ileostomy in the entire cohort was 19.13% (133/695; range within individual centers 4.6-24.32%). Previous treatment with bevacizumab [OR 2.8 (1.3-6.1); p=0.01]; additional bowel resections [OR 3.0 (1.8-5.1); p<0.001]; extended operating time [OR 1.005 (1.003-1.006); p<0.001] and intra-operative red blood transfusion [OR 2.7 (1.4-5.3); p<0.001] were found to be independently associated with diverting ileostomy performance. Assuming a 7% AL rate cut-off, up to 51.8% of DI presented an AL risk below 7% and might have been spared. The risk factors that drive the gynecologic oncology surgeons to perform a diverting ileostomy, seem to differ from the actual risk factors that we have identified to be associated with postoperative anastomotic leak. Broader awareness of the risk factors that contribute to a higher perioperative risk profile, will facilitate a better risk stratification process and possibly avoid unnecessary stoma formation in ovarian cancer patients.
Identifiants
pubmed: 32571682
pii: S0090-8258(20)31132-X
doi: 10.1016/j.ygyno.2020.05.047
pii:
doi:
Substances chimiques
Bevacizumab
2S9ZZM9Q9V
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
603-607Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.